Delivery Order SPE2DB22D9311-SPE2DB25FP7AK
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order valued at $8,184.24 to DMS Pharmaceutical Group Inc. for ENGERIX-B PEDI 10 MCG/0.5 syringe pediatric hepatitis B vaccine on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The vaccine will be delivered to the Park Ridge location and represents a routine...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 18, 2025, for ENGERIX-B pediatric hepatitis B vaccine (10 micrograms/0.5 milliliter syringes). This firm fixed-price delivery order carries a ceiling value of $4,243.68 and is scheduled for completion by July 21, 2025. The contract utilizes no set-aside designation, and performance will occur at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,607.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,362.08 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, with a completion date of June 21, 2024. DMS Pharmaceutical Group holds a larger, single-award, indefinite-delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,395.24 contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a specialized pharmaceutical product, with a completion date of April 10, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,668.88 firm fixed-price contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA, valued at up to...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,757.30, is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of June 13, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing direct...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,756.00 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a period of performance through May 28, 2025. DMS Pharmaceutical Group Inc. has a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...